Lesley Russell - Net Worth and Insider Trading

Lesley Russell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lesley Russell owns 6 companies in total, including Enanta Pharmaceuticals Inc (ENTA) , Endocyte Inc (ECYT) , and AMAG Pharmaceuticals Inc (AMAG) among others .

Click here to see the complete history of Lesley Russell’s form 4 insider trades.

Insider Ownership Summary of Lesley Russell

Ticker	Comapny	Transaction Date	Type of Owner
ENTA	Enanta Pharmaceuticals Inc	2022-03-03	director
ECYT	Endocyte Inc	2018-12-21	director
AMAG	AMAG Pharmaceuticals Inc	2018-06-07	director
INNL	Innocoll Holdings PLC	2017-07-24	Chief Medical Officer
TLOG	TetraLogic Pharmaceuticals Corp	2015-01-28	Chief Operating Officer
SCPS	Scopus BioPharma Inc	2020-12-16	director

Lesley Russell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lesley Russell Ownership Network

Ownership Network List of Lesley Russell

No Data

Ownership Network Relation of Lesley Russell

Lesley Russell Owned Company Details

What does Enanta Pharmaceuticals Inc do?

Who are the key executives at Enanta Pharmaceuticals Inc?

Lesley Russell is the director of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & Business Dev. Brendan Luu , and Sr. VP & New Product Dev. Tara Lynn Kieffer .

Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary

Over the past 18 months, Lesley Russell made no insider transaction in Enanta Pharmaceuticals Inc (ENTA). Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 65,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .

In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,822 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,822 shares.

Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enanta Pharmaceuticals Inc Insider Transactions

No Available Data

What does Endocyte Inc do?

Who are the key executives at Endocyte Inc?

Lesley Russell is the director of Endocyte Inc. Other key executives at Endocyte Inc include VP Finance & Chief Acctg Off Beth Taylor , General Counsel David R. Mcavoy , and Chief Medical Officer Alison A. Armour .

Endocyte Inc (ECYT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endocyte Inc (ECYT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endocyte Inc (ECYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endocyte Inc (ECYT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Endocyte Inc Insider Transactions

No Available Data

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Lesley Russell is the director of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

What does Innocoll Holdings PLC do?

Who are the key executives at Innocoll Holdings PLC?

Lesley Russell is the Chief Medical Officer of Innocoll Holdings PLC. Other key executives at Innocoll Holdings PLC include 10 percent owner Fig Llc , 10 percent owner Fortress Investment Group Llc , and 10 percent owner Fortress Operating Entity I Lp .

Innocoll Holdings PLC (INNL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innocoll Holdings PLC (INNL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innocoll Holdings PLC (INNL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innocoll Holdings PLC (INNL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innocoll Holdings PLC Insider Transactions

No Available Data

What does TetraLogic Pharmaceuticals Corp do?

Who are the key executives at TetraLogic Pharmaceuticals Corp?

Lesley Russell is the Chief Operating Officer of TetraLogic Pharmaceuticals Corp. Other key executives at TetraLogic Pharmaceuticals Corp include other: See Remarks Hudson Bay Capital Management Lp , other: See Remarks Lazard Asset Management Llc , and other: See Remarks Nomura Holdings Inc .

TetraLogic Pharmaceuticals Corp (TLOG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TetraLogic Pharmaceuticals Corp (TLOG)'s detailed insider trading history can be found in Insider Trading Tracker table.

TetraLogic Pharmaceuticals Corp Insider Transactions

No Available Data

What does Scopus BioPharma Inc do?

Who are the key executives at Scopus BioPharma Inc?

Lesley Russell is the director of Scopus BioPharma Inc. Other key executives at Scopus BioPharma Inc include director & Chairman Joshua R Lamstein , See Remarks Alan M Horsager , and director & Vice Chairman Robert J Gibson .

Scopus BioPharma Inc (SCPS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Scopus BioPharma Inc (SCPS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Scopus BioPharma Inc (SCPS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Scopus BioPharma Inc (SCPS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scopus BioPharma Inc Insider Transactions

No Available Data

Lesley Russell Mailing Address

Above is the net worth, insider trading, and ownership report for Lesley Russell. You might contact Lesley Russell via mailing address: 41 Moores Rd., Frazer Pa 19355.

Discussions on Lesley Russell

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.